Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ESMO 2012 /
Analysing the efficacy of treatment through Response Evaluation Criteria in Solid Tumors (RECIST)

28th Sep - 2nd Oct 2012

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 09.10.12
Views: 5830

Dr Yves Menu – Saint Antoine Hospital, Paris, France

Dr Yves Menu talks to ecancer about the RECIST system for evaluating the effectiveness of treatments at the 2012 ESMO meeting in Vienna.

RECIST measures tumours morphologically and makes a follow up after treatment to determine efficacy. This is an international standard in treatment as it provides simple indicators that are universally understood.


Filming supported by Amgen

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation